Is BRCA Mutation Testing Cost Effective for Early Stage Breast Cancer Patients Compared to Routine Clinical Surveillance? The Case of an Upper Middle-Income Country in Asia

Overview of attention for article published in Applied Health Economics and Health Policy, March 2018

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

facebook: 1 Facebook page

Citations

dimensions_citation: 14 Dimensions

Readers on

mendeley: 64 Mendeley

Summary X Facebook Dimensions citations

So far, Dimensions has found 14 publications that cite this research output.

14

The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.

Economic evaluation of germline genetic testing for breast cancer in low- and middle-income countries: a systematic review

Article in BMC Cancer (March 2024)

Economic evaluations of predictive genetic testing: A scoping review

Article in PLOS ONE (August 2023)

Cost-Effectiveness of Genetic Testing Strategies for Breast Cancer

Book chapter (February 2023)